The frequency of EGFR And KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy

The frequency of EGFR And KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy

In this study, profiles of epidermal growth factor receptor (EGFR) and Kirsten ras sarcoma (KRAS) mutations and response to erlotinib therapy have been investigated in patients with non-small cell lung cancer (NSCLC). DNA from 300 patients with NSCLC was extracted from paraf-fin-embedded tissues. Af...

Full description

Bibliographic Details
Main Authors: Demiray A, Yaren A, Karagenç N, Bir F, Demiray AG, Karagür ER, Tokgün O, Elmas L, Akça H
Format: Article
Language:English
Published: Sciendo 2018-12-01
Series:Balkan Journal of Medical Genetics
Subjects:
erlotinib therapy
epidermal growth factor receptor (egfr)
kirsten ras sarcoma (kras)
non-small cell lung cancer (nsclc)
Online Access:https://doi.org/10.2478/bjmg-2018-0022

Similar Items

Similar Items